SEARCH RESULTS FOR: 立陶宛U卡(www.usdtcard.org)Ms2M(9964 results)
No Description
DSM BIOMEDICAL, INC.
30052-12
In Commercial Distribution
- M26330052120 ()
- Length: 5 Centimeter
- Width: 5 Centimeter
- Animal-derived wound matrix dressing
No Description
DSM BIOMEDICAL, INC.
30052-11
In Commercial Distribution
- M26330052110 ()
- Length: 3.5 Centimeter
- Width: 3.5 Centimeter
- Animal-derived wound matrix dressing
The exsalt PT7 Contact Layer contains silver that inhibits bacterial growth in the dressing, as shown in-vitro for up to 7 days against Staphylococcus aureus, Enterococcus faecalis, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumanii.
The exsalt PT7 Contact Layer consists of three layers:
Two non adherent polyethylene mesh wound contact layers and an absorbent core made of polyester; all three layers are silver coated. The concentration of silver on the exsalt PT7 Contact Layer is approximately 0.4 mg/cm2 (4.5% w/w).
The exsalt PT7 Contact layer meets pyrogen limit specifications.
The exsalt PT7 Contact Layer is indicated for use in partial and full thickness wounds including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and
second degree burns, grafts, and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and grafted wounds.
Exciton Technologies Inc
PN-09-0130
In Commercial Distribution
- 07540127000536 ()
- 07540127000529 ()
- 07540127000543 ()
- Area/Surface Area: 1680 Square centimeter
CL0466
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0066
In Commercial Distribution
- 07540127000505 ()
- 07540127000499 ()
- 07540127000512 ()
- Area/Surface Area: 512 Square inch
CL1632
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, 4" x 66" in size
Exciton Technologies Inc
BM-09-0166
In Commercial Distribution
- 07540127000468 ()
- 07540127000475 ()
- 07540127000482 ()
T70466
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0065
In Commercial Distribution
- 07540127000444 ()
- 07540127000437 ()
- 07540127000451 ()
- Area/Surface Area: 256 Square inch
CL1616
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0064
In Commercial Distribution
- 07540127000413 ()
- 07540127000406 ()
- 07540127000420 ()
- Area/Surface Area: 128 Square inch
CL0816
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0063
In Commercial Distribution
- 07540127000383 ()
- 07540127000376 ()
- 07540127000390 ()
- Area/Surface Area: 36 Square inch
CL0606
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0062
In Commercial Distribution
- 07540127000352 ()
- 07540127000345 ()
- 07540127000369 ()
- Area/Surface Area: 20 Square inch
CL0405
- Wound-nonadherent dressing, absorbent, antimicrobial
exsalt™ CMC Gelling Fiber Dressing is a soft, sterile, nonwoven wound dressing made of
sodium carboxymethylcellulose (CMC), cellulose fibers, and silver (0.2mg Ag/cm2) (1.7wt/wt%).
The silver in the dressing provides an antibacterial barrier that inhibits bacterial growth in the dressing, as
shown in vitro, for up to seven (7) days against Gram-positive and Gram-negative bacteria. exsalt™ CMC
Gelling Fiber Dressing absorbs high amounts of wound fluid and creates a soft cohesive gel that
intimately conforms to the wound surface and maintains a moist wound healing environment.
Exciton Technologies Inc
PN-09-0126
In Commercial Distribution
- 07540127000321 ()
- 07540127000314 ()
- 07540127000338 ()
- 0.75" x 18"
GF0118
- Exudate-absorbent dressing, hydrophilic-gel, antimicrobial